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Abstract
Background: Weaning-induced pulmonary oedema (WiPO) is a well-recognised cause of failure of weaning from
mechanical ventilation, but its incidence and risk factors have not been reliably described. We wanted to determine
the incidence and risk factors in a population of critically ill patients. In addition, we wanted to describe the effects
of diuretics when they are administered in this context.
Methods: We monitored 283 consecutive spontaneous breathing trials (SBT; T-piece trial) performed in 81 patients.
In cases with cardiac output monitoring (n = 85, 29 patients), a passive leg raising (PLR) test was performed before
SBT. Three experts established the diagnosis of WiPO based on various patient characteristics.
Results: SBT failed in 128 cases (45 % of all SBT). WiPO occurred in 59 % of these failing cases. Compared to patients
without WiPO (n = 52), patients with at least one WiPO (n= 29) had a higher prevalence of chronic obstructive pulmonary
disease (COPD) (38 % vs. 12 %, respectively; p < 0.01), previous “structural” cardiopathy (dilated and/or hypertrophic and/or
hypokinetic cardiopathy and/or significant valvular disease, 9 % vs. 25 %, respectively; p < 0.01), obesity (45 % vs. 17 %,
respectively; p < 0.01), and low left ventricular ejection fraction (55 % vs. 21 %, respectively; p = 0.01). At logistic regression,
COPD (odds ratio (OR) 8.7, 95 % confidence interval (CI) 2.0–37.3), previous structural cardiopathy (OR 4.5, 95 % CI 1.4–14.
1), and obesity (OR 3.6, 95 % CI 1.2–12.6) were independent risk factors for experiencing at least one episode of WiPO. In
16 cases with WiPO and a negative PLR at baseline, treatment including diuretics was started. In 9 of these cases, the PLR
remained negative before the following SBT. A new episode of WiPO occurred in 7 of these instances, while the two
other were extubated. In 7 other cases, the PLR became positive before the following SBT. WiPO did not occur anymore
in 6 of these 7 patients who were extubated, while the remaining one was not.
Conclusions: In our population of critically ill patients, WiPO was responsible for 59 % of weaning failures. COPD, previous
“structural” cardiopathy, and, to a lesser extent, obesity were the main risk factors. When a treatment including
fluid removal had changed preload-independence to preload-dependence, the following SBT was very likely to succeed.
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Background
Failure of weaning from mechanical ventilation increases
the length of mechanical ventilation and length of stay
in the intensive care unit and it is associated with poor
outcome [1, 2]. Among the causes of weaning failure,
weaning-induced pulmonary oedema (WiPO) is related
to the transition from a positive pressure to a negative
pressure regimen of ventilation, which creates unfavour-
able loading conditions for the heart (increase in right
and left ventricular preload, and increase in right and
left ventricular afterload) and, potentially, induces myo-
cardial ischaemia [3–5].
The incidence of WiPO has not been clearly estab-
lished. The studies that reported it were of small size
and/or included specific populations of patients [6–11].
Moreover, the risk factors for WiPO and the incidence
of myocardial ischaemia as a cause of WiPO have been
reported only in studies of small size [6–13]. Our group
previously showed that WiPO is highly associated with
preload independence at the time of the spontaneous
breathing trial (SBT) [9]. In this regard, the effects of fluid
removal as a treatment for WiPO need to be described.
In a population of critically ill patients, we aimed at: 1)
describing the incidence of WiPO; 2) describing the
characteristics of patients who experienced WiPO; 3) in-
vestigating myocardial ischaemia as a cause of WiPO;
and 4) describing in detail the effects of fluid removal on
WiPO. In particular, we wanted to test whether the risk
of WiPO decreases when a treatment including fluid
removal fosters a preload-dependence status.
Methods
Patients
The study was approved by our institutional review board
(Comité pour la protection des personnes Ile-de-France
VII). All patients were informed about the study and gave
their consent to participate. They were included once
withdrawal of mechanical ventilation was decided. The
only exclusion criterion was tracheostomy.
Spontaneous breathing trial
The decision to perform a SBT was taken when the
following criteria of readiness to start the weaning
process were fulfilled: inspired oxygen fraction below
50 %, positive end-expiratory pressure below 5 cm H2O,
Ramsay score of 2–3, cough during tracheal suctioning,
and absence of vasopressor administration.
In all patients, SBT was performed on a “T-piece”
connected to an oxygen source. The maximum dur-
ation for an SBT was set at 1 h, except in patients with
a neurologic deficit where it could be prolonged. The
poor tolerance of SBT was defined as the occurrence of
dyspnoea and/or an oxygen desaturation and/or hyper-
capnia and/or heart rate ≥140 beats per minute and/or
systolic arterial pressure ≥180 mmHg [14]. If patients
failed the SBT, they were reconnected to the ventilator.
SBT was repeated the next day, according to the deci-
sion of the clinicians in charge, until extubation or
death. If they thought SBT failure was due to WiPO,
the clinicians in charge administered diuretics before
the next SBT. In some patients, they also decided to ad-
minister nitrates during the next WiPO or angiotensin-
converting enzyme inhibitors before the next SBT.
Administration of these treatments was not standar-
dised but left to the discretion of the clinicians in
charge of the patient.
Recorded variables
Before starting the SBT, we recorded some demo-
graphic data. In particular, we looked for past hyperten-
sion, chronic obstructive pulmonary disease (COPD),
dilated, hypertrophic or hypokinetic cardiopathy, sig-
nificant valvular disease (aortic or mitral insufficiency
of grade ≥2, mild or severe aortic and mitral stenosis), car-
diac arrhythmias, and coronary artery disease. “Structural
cardiopathy” was defined as dilated and/or hypertrophic
and/or hypokinetic cardiopathy and/or significant valvular
disease. The diagnosis of COPD was established using the
following criteria: chronic and progressive dyspnoea,
cough, and sputum production [15]. These symptoms
were collected from the patient’s previous medical reports
or from the words of the patient or their relatives. The
patient’s weight was measured using scales every day, and
from this we calculated weight gain from admission. Fluid
balance over the last 24 h, duration of mechanical ventila-
tion before SBT, respiratory rate, heart rate, and systemic
arterial pressure were also recorded. Before starting
SBT we also collected the results of arterial blood gas
analysis, electrocardiogram, and biological tests includ-
ing troponin Ic, haemoglobin, and plasma protein
concentrations.
Before starting SBT, an echocardiography (CX50, Phi-
lips Healthcare, Andover, CA, USA) examination was
performed by two investigators (JL and FS). In
particular, this assessed the left ventricular ejection
fraction (biplane or monoplane Simpson method), E
and A waves of the mitral flow, and E’ wave of the ex-
ternal mitral annulus [16].
Before starting SBT, in cases where a transpulmonary
thermodilution device was in place (PiCCO2, Pulsion
Medical Systems, Munich, Germany), three successive
measurements were performed and averaged [17]. We
measured cardiac index, global end-diastolic volume,
and extravascular lung water [18]. A passive leg raising
(PLR) test was also performed [19]. This has been dem-
onstrated to detect preload dependence [20].
The SBT was then started. Before reconnecting the pa-
tient to the ventilator, we recorded the same variables as
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before the SBT, except troponin Ic which was reassessed
4 h after SBT. On the electrocardiogram (ECG) we
looked for inversion of T waves and depression or eleva-
tion of the ST segment compared to the previous ECG. If
the patients completed the SBT correctly, they were
extubated. Patients that were extubated but who needed
to be reintubated or to be placed under non-invasive ventila-
tion within the next 48 h were classified as failing the SBT.
Diagnosis of WiPO
The diagnosis of WiPO was established by three experts
(NA, JLT, and XM) on a beam of argument. They particu-
larly took into account failure or success of SBT, increases
in haemoglobin and plasma protein concentrations [10],
increases in heart rate and/or arterial pressure, increases in
the ratio of the E and A waves of the mitral flow, and of the
ratio of the E wave of the mitral flow over the E' wave of
the mitral annulus. In patients with a PiCCO2 device, they
also took into account the changes in transpulmonary ther-
modilution variables during the SBT [8]. The experts were
unaware of past medical history, fluid balance and weight
changes, occurrence of myocardial ischaemia on ECG,
changes in troponin Ic levels, and changes in blood gas ana-
lysis. In addition, since we wanted to test whether the risk
of WiPO decreased when a treatment including fluid
removal changed preload independence to preload depend-
ence, experts were unaware of the results of the PLR test.
Statistics
Data are expressed as mean +/- standard deviation or me-
dian (interquartile range), as appropriate. Comparisons
between before and the end of the SBT were assessed with
a paired Student’s t test or a Wilcoxon signed rank sum
test. Comparisons of variables between patients with
and patients without WiPO were assessed by a two-
tailed Student t test or a Mann–Whitney U test.
To investigate risk factors for WiPO, we performed a
forward logistic regression where the occurrence of at
least one episode of WiPO was the dependent variable
and where the explanatory variables were a past med-
ical history of COPD, a past medical history of struc-
tural cardiopathy, the presence of obesity, and the
Simplified Acute Physiology Score (SAPS) II. For these
variables, there was a significant difference (p < 0.05) at
univariate analysis between patients with at least one
episode of WiPO and those without. Among the other
variables that were different between patients with at
least one episode of WiPO and those without, age was
not included in the logistic regression because it was
correlated with SAPS II and the “low ejection fraction”
criterion was not included because it was significantly
associated with “structural cardiopathy”. The adjusted
odds ratio (OR) and the 95 % confidence interval (CI))
were calculated for all independent factors associated
with the risk of presenting at least one episode of
WiPO. A p value <0.05 was considered significant. The
statistical analysis was performed with the software




Eighty-one patients performed 283 SBT. Of these, 155
cases were successful and 128 cases were not (Fig. 1).
The planned duration of SBT was 1 h in all cases. In
127 of those 128 deemed to have failed SBT, SBT failed
immediately and the patients were not extubated. In
one case, SBT seemed to be initially successful and the
patient was extubated, but respiratory failure led to
reintubation within 48 h. In four cases, the experts
could not reach a conclusion regarding the occurrence
of WiPO, and they were excluded from further analysis
(Fig. 1). WiPO occurred in 75 (27 %) of the SBT, all of
which failed the SBT. Thus, WiPO occurred in 59 % of
cases with weaning failure. Among the 81 SBT that
were performed first in each patient, WiPO occurred in
14 instances. Twenty-nine patients experienced at least
one WiPO and 52 patients experienced no WiPO.
Among those patients who did not experience any epi-
sodes of WiPO, four died and the others were eventu-
ally extubated. Patients who experienced at least one
episode of WiPO had undergone 6 (interquartile range
3–7) unsuccessful SBT before being extubated, while 2
(interquartile range 1–2) attempts were necessary in
patients without any episode of WiPO. Weaning was
simple in 35 (43 %) patients, difficult in 19 (23 %) pa-
tients, prolonged in 25 (31 %) patients, and 2 (2 %)
patients died before being weaned. The incidence of














Fig. 1 Flow chart. SBT spontaneous breathing trial, WiPO weaning-
induced pulmonary oedema
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WiPO was 2 %, 32 %, 84 %, and 100 % in these groups,
respectively.
Patient characteristics
Compared to patients without WiPO, patients with at
least one episode of WiPO had a significantly higher
prevalence of COPD, “structural” cardiopathy, low left
ventricular ejection fraction, and obesity (Table 1, Fig. 2).
In two patients without WiPO and four patients with
WiPO, obesity had been previously recognised as re-
sponsible for a restrictive chronic respiratory failure. At
logistic regression, COPD, structural cardiopathy, and
obesity were independently associated with the risk of
presenting one episode of WiPO (Table 2). SAPS II was
not independently associated with the risk of presenting
one episode of WiPO (p = 0.06).
In 85 of the 283 cases (29 patients), a device for moni-
toring cardiac output was in place at the time of SBT.
Thirty of these cases were accompanied by WiPO. The
PLR-induced increase in cardiac index was significantly
higher in cases with WiPO than in the others (Table 3,
Fig. 3).
Changes during SBT
The baseline characteristics of all cases with and without
WiPO are presented in Table 4. There was no significant
difference between SBT with and without WiPO regarding
the fluid balance over the last 24 h (Table 4).
Table 1 Patient characteristics at inclusion
All patients Patients with at least one WiPO Patients without any WiPO P valuea
(n = 81) (n = 29) (n = 52)
Age (years) 62 ± 15 67 ± 12 60 ± 16 0.03
Male gender 41 (51 %) 14 (48 %) 27 (52 %)
Simplified Acute Physiology Score II 47 ± 18 53 ± 22 43 ± 14 0.01
Body mass index (on admission) 27 ± 8 31 ± 10 24 ± 6 <0.01
Obesity 22 (27 %) 13 (45 %) 9 (17 %) 0.01
Aetiology of intubation
Pneumonia 35 (43 %) 13 (45 %) 22 (42 %) 0.99
Septic shock without pneumonia 27 (33 %) 10 (34 %) 17 (33 %) 0.93
Coma 6 (7 %) 0 (0 %) 6 (7 %) <0.01
Drug poisoning of other origin 2 (2 %) 0 (0 %) 2 (2 %) <0.01
Neuromuscular disease 5 (6 %) 0 (0 %) 5 (10 %) 0.07
Cardiogenic shock 4 (5 %) 4 (14 %) 0 (0 %) 0.01
Exacerbation of COPD 2 (2 %) 2 (7 %) 0 (0 %) 0.24
Previous COPD 17 (21 %) 11 (38 %) 6 (11 %) 0.01
Previous cardiovascular diseases
Hypertension 53 (65 %) 22 (76 %) 31 (60 %) 0.22
Atrial fibrillation 13 (16 %) 9 (31 %) 4 (8 %) 0.01
“Structural” cardiopathy 32 (39 %) 19 (69 %) 13 (25 %) 0.00
Dilated cardiopathy 23 (28 %) 14(48 %) 9 (17 %) 0.00
Hypertrophic cardiopathy 7 (4 %) 4 (3 %) 3 (4 %) 0.41
Significant valvular disease 2 (2 %) 1 (3 %) 1 (2 %) 0.75
Coronary artery disease 13 (16 %) 6 (21 %) 7 (13 %) 0.59
Sepsis-related cardiopathy 6 (6 %) 5 (17 %) 1 (2 %) 0.01
Left ventricular ejection fraction <45 % 27 (33 %) 16 (55 %) 11 (21 %) <0.01
Total ventilation duration (days) 13 ± 14 20 ± 15 8 ± 12 <0.01
Ventilation duration before the first SBT (days) 6 ± 7 6 ± 6 4 ± 5 0.06
Total duration of ICU stay (days) 17 ± 16 26 ± 16 12 ± 14 <0.01
ICU mortality 6 (7 %) 2 (7 %) 4 (8 %) 0.76
Values are expressed as mean ± standard deviation or number and frequency (%)
aPatients with at least one WiPO vs. patients without WiPO
COPD chronic obstructive pulmonary disease, ICU intensive care unit, SBT spontaneous breathing trial, WiPO weaning-induced pulmonary oedema
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The duration of SBT was 60 ± 0 min in cases with
weaning success, 50 ± 16 min in cases with weaning failure
without WiPO (significantly lower than for cases without
weaning success), and 48 ± 17 min in cases with weaning
failure and WiPO (significantly lower than for cases with
weaning success but not different from cases with weaning
failure without WiPO). Haemodynamic and biological
changes are presented in Tables 5 and 6. The concentra-
tion of haemoglobin and of plasma protein at baseline was
significantly lower in the 75 cases with WiPO than in the
204 cases without (Table 6).
During SBT, the increase in PaCO2 was significantly
higher when SBT failed than if it did not. If SBT failed,
the increase in PaCO2 was significantly higher in cases
with WiPO than in cases without WiPO (Table 6).
The haemoglobin concentration increased in cases
with WiPO but not in cases without WiPO, regardless
of the success or failure of SBT (Table 6). This was also
the case for plasma protein concentration (Fig. 3).
In cases with transpulmonary thermodilution monitoring
(n = 85), extravascular lung water significantly increased in
cases with WiPO but not in cases without WiPO, regard-
less of the success or failure of SBT (Fig. 3).
Myocardial ischaemia
Troponin Ic increased more than 0.5 ng/mL in none of
the cases (Table 6). Changes in the ECG occurred in 5
cases that succeeded and in 5 cases that failed SBT;
among those that failed SBT, the incidence of ECG
changes was similar in cases with and without WiPO.
All the observed changes in ECG consisted of ST de-
pression of less than 1 mm.
Treatment and preload dependence
Among the 85 cases (in 29 patients) where a transpul-
monary thermodilution device was present, WiPO was
seen in 30 of them and did not occur in 55. In 28 of the
30 cases with WiPO, the PLR test was negative. Con-
versely, in the 55 cases without WiPO, the PLR test was
always positive (Fig. 4). Haemodynamic changes during
PLR tests are presented in Table 3.
Among the 28 cases with transpulmonary thermodilu-
tion where WiPO and a negative PLR test were present,
fluid removal by diuretics was started in addition to
nitrates and angiotensin-conversting enzyme inhibitor
administration in 16 instances (Fig. 4). Among cases
where this treatment did not change the result of the
PLR test (remaining negative), WiPO occurred again in
a very large majority of cases. By contrast, among cases
where the PLR test had changed from negative to posi-
tive with the treatment, the next SBT succeeded without
WiPO in a large majority of cases (Fig. 4).
Discussion
In our population of critically ill patients, we found that
WiPO was responsible for 59 % of cases of weaning
failure. Previous COPD, cardiopathy, and, to a lesser
extent, obesity were independent risk factors for pre-
senting WiPO. In cases of WiPO, the incidence of myo-
cardial ischaemia during SBT was very low, and it was
never accompanied by a significant increase in troponin
Ic. After a failed SBT with WiPO, when treatment in-
cluding fluid removal had changed the PLR test from
negative to positive, the following SBT was very likely
to succeed.
The studies that investigated WiPO [6–11] did not
provide a clear picture of the epidemiology of WiPO
and, in particular, how common it is. These studies
were limited by the small population size [7, 11] or by
the fact that they included only difficult-to-wean pa-
tients [7–11]. Moreover, the therapeutic strategy was
not systematically investigated in these studies. In this
regard, the main advantage of our study is that it in-


















Fig. 2 Prevalence of risk factors associated with weaning-induced
pulmonary oedema (WiPO) depending on the presence (+) or absence
(–) of the disease. “Cardiopathy” means dilated and/or hypertrophic
and/or hypokinetic cardiopathy and/or significant valvular disease.
COPD chronic obstructive pulmonary disease. * p <0.05 WiPO+
vs. WiPO-
Table 2 Summary of the results of forward logistic regression
with the occurrence of at least one episode of weaning-induced
pulmonary oedema as the dependent variable
Explaining variable Odds ratio (95 % CI) P value
Previous COPD 8.7 (2.0–37.3) 0.003
Previous structural cardiopathy 4.5 (1.4–14.1) 0.001
Obesity 3.6 (1.2–12.6) 0.03
CI confidence interval, COPD chronic obstructive pulmonary disease
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Table 3 Haemodynamic variables during PLR
P values




Failed SBT vs. succeeded
SBT before PLR
Failed SBT vs. succeeded
SBT during PLR
Cases without
WiPO vs. cases with
WiPO before PLR
Cases without WiPO
vs. cases with WiPO
during PLR
Heart rate (beats/min)
Succeeded SBT (n = 40) 84 ± 17 86 ± 16 4 ± 10 % 0.03
Failed SBT (n = 45) 91 ± 18 94 ± 19 3 ± 10 % 0.06 0.05 0.04
Cases with WiPO (n = 30) 90 ± 16 93 ± 17 4 ± 12 % 0.15
Cases without WiPO (n = 15) 94 ± 22 96 ± 22 3 ± 6 % 0.07 0.49 0.59
Systolic arterial pressure (mmHg)
Succeeded SBT (n = 40) 133 ± 24 141 ± 23 6 ± 8 % <0.01
Failed SBT (n = 45) 125 ± 20 130 ± 21 5 ± 10 % <0.01 0.10 0.04
Cases with WiPO (n = 30) 129 ± 18 135 ± 18 6 ± 8 % <0.01
Cases without WiPO (n = 15) 117 ± 23 120 ± 25 3 ± 12 % 0.35 0.07 0.03
Mean arterial pressure (mmHg)
Succeeded SBT (n = 40) 89 ± 16 95 ± 17 8 ± 10 % <0.01
Failed SBT (n = 45) 86 ± 12 91 ± 13 6 ± 11 % <0.01 0.40 0.18
Cases with WiPO (n = 30) 88 ± 12 94 ± 12 7 ± 9 % <0.01
Cases without WiPO (n = 15) 83 ± 14 85 ± 12 3 ± 14 % 0.53 0.24 0.03
Diastolic arterial pressure (mmHg)
Succeeded SBT (n = 40) 64 ± 12 68 ± 12 7 ± 12 % 0.05
Failed SBT (n = 45) 64 ± 9 69 ± 10 9 ± 12 % <0.01 0.79 0.85
Cases with WiPO (n = 30) 64 ± 9 71 ± 10 11 ± 11 % <0.01
Cases without WiPO (n = 15) 63 ± 9 65 ± 9 4 ± 13 % 0.36 0.79 0.09
Cardiac index (L/min/m2)
Succeeded SBT (n = 40) 3.4 ± 0.7 3.7 ± 0.7 15 ± 13 % <0.01
Failed SBT (n = 45) 3.5 ± 0.8 3.8 ± 1.0 7 ± 16 % 0.01 0.24 0.64
Cases with WiPO (n = 30) 3.7 ± 0.9 3.8 ± 0.9 3 ± 7 % 0.06
Cases without WiPO (n = 15) 3.2 ± 0.6 3.7 ± 1.2 17 ± 24 % 0.02 0.03 0.60
Cases with increase in cardiac index ≥10 % during PLR
Succeeded SBT (n = 40) 28 (70 %)
Failed SBT (n = 45) 10 (22 %) <0.01
Cases with WiPO (n = 30) 2 (7 %)
Cases without WiPO (n = 15) 8 (53 %) <0.01
Values are expressed as mean ± standard deviation or number and frequency (%)




















































































































































At the end 
of SBT
Fig. 3 Changes in haemodynamic variables, plasma protein concentration, and extravascular lung water during the spontaneous breathing trial
(SBT). *p < 0.05 at the end of SBT vs. before SBT; #p < 0.05 cases without WiPO vs. cases with WiPO. CI cardiac index, EVLW extravascular lung
water, PLR passive leg raising, SBP systolic arterial blood pressure, WiPO weaning-induced pulmonary oedema
Table 4 Characteristics of all cases with WiPO and of all cases without WiPO
Cases with WiPO Cases without WiPO P valuea
(n = 75) (n = 204)
Weight gain since admission (%) 11 ± 15 6 ± 16 0.10
Fluid balance over the last 24 h (mL) 292 (−698 to 1023) 300 (−453 to 1115) 1.00
Mechanical ventilation duration before SBT (days) 11 ± 7 11 ± 10 0.68
Left ventricular ejection fraction at baseline (%) 61 ± 13 57 ± 11 0.76
E/E' ratio of the mitral flow at baseline 10.5 ± 4.3 8.8 ± 3.2* <0.01
ScvO2 at baseline (%) 72 ± 6 72 ± 8 0.86
Duration of SBT (min) 48 ± 17 56 ± 11* <0.01
Values are expressed as mean ± standard deviation or median (interquartile range)
aCases with at least one WiPO vs. cases without WiPO
SBT spontaneous breathing trial, ScvO2 oxygen saturation of the central venous blood, WiPO weaning-induced pulmonary oedema
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Table 5 Haemodynamic variables before and at the end of SBT
P values
Baseline At the end of SBT At the end of SBT
vs. baseline
Succeeded SBT vs. failed
SBT at baseline
Succeeded SBT vs.
failed SBT at the end
of SBT
Cases with WiPO vs.
cases without WiPO
at baseline
Cases with WiPO vs.
cases without WiPO
at the end of SBT
Heart rate (beats/min)
Succeeded SBT (n = 155) 91 ± 15 93 ± 16 0.093
Failed SBT (n = 124) 91 ± 15 101 ± 18 0.000 0.80 <0.01
Cases with WiPO (n = 75) 89 ± 15 102 ± 18 0.000
Cases without WiPO (n = 49) 93 ± 14 99 ± 17 0.011 0.10 0.37
Systolic arterial pressure (mmHg)
Succeeded SBT (n = 155) 134 ± 22 136 ± 22 0.214
Failed SBT (n = 124) 135 ± 23 144 ± 26 0.000 0.70 <0.01
Cases with WiPO (n = 75) 138 ± 23 152 ± 26 0.000
Cases without WiPO (n = 49) 130 ± 22 131 ± 22 0.716 0.06 <0.01
Mean arterial pressure (mmHg)
Succeeded SBT (n = 155) 89 ± 13 88 ± 14 0.478
ailed SBT (n = 124) 90 ± 15 94 ± 18 0.002 0.87 <0.01
Cases with WiPO (n = 75) 92 ± 16 100 ± 18 0.000
Cases without WiPO (n = 49) 87 ± 15 87 ± 15 0.983 0.09 <0.01
Diastolic arterial pressure (mmHg)
Succeeded SBT (n = 155) 67 ± 11 68 ± 12 0.764
Failed SBT (n = 124) 66 ± 12 69 ± 14 0.021 0.53 0.35
Cases with WiPO (n = 75) 67 ± 12 72 ± 14 0.006
Cases without WiPO (n = 49) 65 ± 11 65 ± 12 0.30 0.01
Cardiac index (L/min/m2)
Succeeded SBT (n = 40) 3.4 ± 0.7 3.9 ± 1 0.000
Failed SBT (n = 45) 3.2 ± 0.7 3.6 ± 1 0.001 0.13 0.13
Cases with WiPO (n = 30) 3.2 ± 0.7 3.8 ± 1 0.000









Table 5 Haemodynamic variables before and at the end of SBT (Continued)
Global end-diatolic volume (mL/m2)
Succeeded SBT (n = 40) 825 ± 254 880 ± 177 0.199
Failed SBT (n = 45) 815 ± 225 916 ± 287 0.002 0.88 0.59
Cases with WiPO (n = 30) 849 ± 133 1032 ± 233 0.000
Cases without WiPO (n = 15) 632 ± 166 624 ± 187 0.718 0.01 <0.01
Extravascular lung water (mL/kg)
Succeeded SBT (n = 40) 10 ± 5 11 ± 3 0.874
Failed SBT (n = 45) 11 ± 3 12 ± 4 0.020 0.91 0.09
Cases with WiPO (n = 30) 11 ± 3 14 ± 4 0.030
Cases without WiPO (n = 15) 9 ± 5 10 ± 1 0.296 0.05 0.01
Values are expressed as mean ± standard deviation









Table 6 Biological variables and electrocardiogram before and at the end of SBT
P values
Baseline At the end of SBT
(except for troponin
Ic, measured at 4 h)
At the end of
SBT vs. baseline
Succeeded SBT vs.
failed SBT at baseline
Succeeded SBT vs. failed
SBT at the end of SBT
Cases with WiPO vs. cases
without WiPO at baseline
Cases with WiPO vs.
cases without WiPO
at the end of SBT
PaCO2 (mmHg)
Succeeded SBT (n = 155) 37 ± 7 38 ± 7
Failed SBT (n = 124) 40 ± 8 46 ± 17 <0.01 <0.01 <0.01
Cases with WiPO (n = 75) 41 ± 9 50 ± 18 <0.01
Cases without WiPO (n = 49) 39 ± 7 41 ± 12 0.11 0.01
PaO2 (mmHg)
Succeeded SBT (n = 155) 105 ± 27 97 ± 37 0.03
Failed SBT (n = 124) 96 ± 22 72 ± 17 <0.01 <0.01 <0.01
Cases with WiPO (n = 75) 93 ± 17 71 ± 16 <0.01
Cases without WiPO (n = 49) 101 ± 27 74 ± 20 <0.01 0.05 0.52
Haemoglobin (g/dL)
Succeeded SBT (n = 155) 9.9 ± 1.4 10.0 ± 1.5
Failed SBT (n = 124) 9.4 ± 1.4 10.0 ± 1.5 <0.01 <0.01 0.81
Cases with WiPO (n = 75) 9.1 ± 1.2 10.2 ± 1.3 <0.01
Cases without WiPO (n = 49) 9.7 ± 1.5 9.5 ± 1.6 0.04 0.02
Plasma protein concentration (g/L)
Succeeded SBT (n = 155) 58 ± 11 59 ± 11 0.01
Failed SBT (n = 124) 55 ± 9 57 ± 9 <0.01 0.02 0.19
Cases with WiPO (n = 75) 53 ± 9 58 ± 10 <0.01
Cases without WiPO (n = 49) 58 ± 9 57 ± 8 0.00 0.60
Troponin Ic (ng/mL)
Succeeded SBT (n = 155) 0.07 ± 0.13 0.09 ± 0.06 0.08
Failed SBT (n = 124) 0.10 ± 0.08 0.10 ± 0.06 1.00 0.03 0.17
Cases with WiPO (n = 75) 0.11 ± 0.08 0.11 ± 0.08 1.00
Cases without WiPO (n = 49) 0.07 ± 0.10 0.09 ± 0.09 0.30 0.02 0.20
Patients with increase in troponin Ic >0.5 ng/mL









Table 6 Biological variables and electrocardiogram before and at the end of SBT (Continued)
Failed SBT (n = 124) – 0 (0 %)
Cases with WiPO (n = 75) – 0 (0 %)
Cases without WiPO (n = 49) – 0 (0 %)
Patients with changes in electrocardiogram
Succeeded SBT (n = 155) – 5 (3 %)
Failed SBT (n = 124) – 5 (4 %)
Cases with WiPO (n = 75) – 4 (5 %)
Cases without WiPO (n = 49) – 1 (2 %)
Values are expressed as mean ± standard deviation or number and frequency (%)









patients where the treatment that was undertaken in
case of WiPO was clearly described.
In our large series of SBT, WiPO occurred in more
than half of all SBT. This result confirms what has been
suggested by smaller sized studies [6–11], which re-
ported an incidence of weaning-induced cardiac dys-
function ranging from 44 % [7] to 87 % of weaning
failures [6]. This result suggests that WiPO must be
recognised as a very common cause of weaning failure.
Clinicians should carefully look for this when facing a pa-
tient who fails SBT, using one of the several methods that
have been described for this purpose. Nevertheless, it is im-
portant to take into account that all SBT in our study were
performed with a T-piece, a method of SBT that is much
more challenging for the heart than pressure support [11].
Previous COPD and “structural” cardiopathy were two
factors that were independently and strongly associated
with WiPO. Although such conditions are commonly
suggested to be associated with WiPO [4, 5, 21], this has
rarely been reported [11]. Moreover, as far as we know,
our study is the first to demonstrate with logistic regres-
sion that these are independent risk factors for WiPO.
COPD favours the SBT-induced haemodynamic distur-
bances that underlie WiPO [4, 21]. Essentially, it is
responsible for very large negative swings in intratho-
racic pressure during SBT [13], which is one of the
primum movens of cardiac dysfunction during wean-
ing [4, 5, 21]. Also, the chronic right ventricular fail-
ure of these patients may aggravate the deleterious
effects of SBT for the right ventricle, such as biventri-
cular interdependence [22, 23].
Obesity was another independent risk factor of WiPO.
It was observed in almost half of patients who experi-
enced at least one episode of WiPO and was rarely
responsible for previously diagnosed respiratory failure.
As far as we know, it has never been reported before. In
fact, it seems that body mass index (BMI) was not inves-
tigated in previous studies or, at least, not reported.
Obesity reduces functional residual capacity and expira-
tory flows and increases airway resistance [24], all con-
ditions that may contribute to WiPO. However, the
association between obesity and the risk of WiPO was
weaker than for COPD and previous cardiopathy. This re-
sult should ideally be confirmed by future observations.
Cases with cardiac output 
monitoring
No WiPO WiPO







at the next SBT
No WiPO
at the next SBT
WiPO
at the next SBT
No WiPO
at the next SBT
+ nitrates in 4 cases
+ ACE in 2 cases
+ nitrates in 3 cases
+ ACE in 2 cases
85 cases
55 cases 30 cases
28 cases2 cases
16 cases 12 cases
7 cases9 cases






at the next SBT
No WiPO
at the next SBT
WiPO
at the next SBT
No WiPO
at the next SBT
1 case11 cases
9 cases 2 cases 0 case 1 case
Fig. 4 Effects of treatment on the issue of spontaneous breathing trial (SBT) depending on the result of a passive leg raising (PLR) test. ACE
angiotensin-converting enzyme, WiPO weaning-induced pulmonary oedema
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Another important observation was that myocardial
ischaemia (as detected by ECG changes) during SBT
was uncommon and that, when it occurred, it was mild,
without any increases in troponin Ic. The incidence of
myocardial ischaemia as a cause of weaning failure was
very different among previous publications [12], ran-
ging from 6 % [25] to 50 % [26]. Many of these previous
studies had included a large proportion of patients with
coronary artery disease. Although it has been reported
that myocardial ischaemia could be the main mechanism
of cardiac failure during weaning in some instances, and
that its treatment may improve the weaning success in
such cases [27], this mechanism is far from common.
Our group previously reported that WiPO is associ-
ated with preload independence [9]. To explain this ob-
servation, we hypothesised, first, that in case of preload
independence of the right ventricle, the increase in ven-
ous return and the increase in right ventricular afterload
during SBT are likely to result in a further right ven-
tricular dilation. This may lead to a right-to-left shift of
the interventricular septum. Second, preload independence
of the left ventricle is likely to be associated with left ven-
tricular failure. In this condition, diastolic left ventricular
dysfunction is common, so that a further SBT-induced in-
crease in left ventricular preload (volume) may result in a
large increase in left ventricular end-diastolic pressure. Fur-
thermore, a failing left ventricle is more sensitive to in-
creases in its afterload. The SBT-induced increase in left
ventricular afterload is thus more likely to increase left ven-
tricular end-diastolic pressure.
The present study confirms our previous observation
[9]. Furthermore, it describes the effects of fluid removal
on the incidence of WiPO, an observation that we did
not make in our previous study [9]. In cases of WiPO
with a negative PLR, when treatment including fluid
removal had changed the PLR test from negative to posi-
tive, the success of the next SBT was very likely. In
contrast, if the PLR test remained negative, most of the
patients failed the next SBT. These results suggest that,
when treatment including fluid removal is chosen for
treating WiPO, it should be conducted with the goal of
reaching a preload-dependent condition. It has been
demonstrated that a strategy leading to fluid depletion
reduced the duration of ventilation [28]. Nevertheless,
definitive proof of the benefit of PLR-guided fluid re-
moval would only come from a study comparing WiPO
cases treated with this strategy and other strategies.
A first limitation of our study is that the diagnosis of
WiPO was established by the consensual appraisal of ex-
perts. However, the experts based their diagnosis on several
variables, including some that have been demonstrated to
diagnose lung oedema at least as well as the pulmonary
artery catheter [9, 10]. As a second limitation, we recorded
all the SBT in every patient who underwent more than one
SBT. This increased the proportion of unsuccessful SBT.
Nevertheless, the analysis of the risk factors for WiPO
was based on patients and not on all cases. Moreover,
including the same patient for several SBT was neces-
sary to evaluate the therapeutic strategy. Third, the ex-
ternal validity of our single-centre study is limited. In
particular, the incidence of weaning failure was high.
This is likely explained by the fact that the risk factors
for weaning failure in our patients were high. Our
population included no post-surgery patients, and more
than 75 % of patients had been intubated because of
pneumonia or septic shock of another origin. Finally,
we did not record the total fluid balance of our patients
but used the weight gain as an indirect marker of fluid
accumulation.
Conclusions
In our population of critically ill patients, WiPO was re-
sponsible for 59 % of weaning failures. Previous COPD,
cardiopathy, and, to a lesser degree, obesity, were inde-
pendent risk factors for WiPO. These results may warn
clinicians about the importance of this diagnosis and
should encourage them to look for it in patients at risk.
WiPO was associated with a preload-independence con-
dition. When a treatment including fluid removal had
changed preload independence to preload dependence,
the following SBT was very likely to succeed. It should
be further investigated whether, in patients with WiPO,
fluid should be removed until preload dependence appears.
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